Severe exposure keratopathy secondary to oncologic surgery in a patient with epidermodysplasia verruciformis
DOI:
https://doi.org/10.25251/rh02q605Keywords:
cancer, carcinoma, cornea, eyelid, skinAbstract
The case of a 43-year-old woman who presented with multiple exophytic lesions on both eyelids of the left eye is described. The patient underwent excisional biopsy of the lesions, and later 2 more interventions were necessary for the excision of the affected margins. She was followed by dermatology and medical oncology specialists, as she presented several skin tumors in other locations. Two years after the intervention, she developed a lower corneal abscess in the left eye, with cultures positive for Candida spp. Approximately 12 months later, the infection had completely resolved, leaving a leukoma with both superficial and deep vascularization in the lower cornea. Lagophthalmos was observed along with a predominantly lateral cicatricial ectropion of the lower eyelid, accompanied by increased corneal vascularization, lipoid degeneration, and greater central opacity. The patient underwent cauterization of the superficial vessels and intrastromal bevacizumab injection into the deep vessels and has now been offered penetrating keratoplasty. Epidermodysplasia verruciformis is a rare skin condition characterized by the development of squamous cell carcinomas and flat warts. When these lesions involve the eyelid, close communication between dermatologists, corneologists, and oculoplastic surgeons is essential for optimal management of these patients.
References
1. Burger B., Itin P.H. Epidermodysplasia verruciformis. Curr Probl Dermatol. 2014;45:123–131. PMID: 24643182
2. Majewski S, Jabłońska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol. 1995;131(11):1312-8. PMID: 7503577
3. Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol. 1997;36(5 Pt 1):659-85; quiz 686-8. PMID: 9146528
4. Jablonska S, Majewski S. Epidermodysplasia verruciformis: immunological and clinical aspects. Curr Top Microbiol Immunol. 1994;186:157-75. PMID: 8205840
5. Przybyszewska J., Zlotogorski A., Ramot Y. Re-evaluation of epidermodysplasia verruciformis: reconciling more than 90 years of debate. J Am Acad Dermatol. 2017;76(6):1161–1175. PMID: 28196644
6. Lutzner M.A., Blanchet-Bardon C., Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol. 1984;83(1 Suppl):18s–25s. PMID: 6330217
7. Wang L, Fang H, Shao A, Zhang H, Ye J. Eyelid squamous cell carcinoma in the setting of epidermodysplasia verruciformis diagnosed by next-generation sequencing: a case report and literature review. Adv Ophthalmol Pract Res. 2022;26;2(3):100066. PMID: 37846292
8. Chen Q., Jiang L., Shi L., et al. Successful treatment of upper-left eyelid squamous cell carcinoma in an epidermodysplasia verruciformis patient by ALA-PDT/holmium laser combination therapy. Photodiagnosis Photodyn Ther. 2021;34. PMID: 33819685
9. Wolkow N, Chodosh J, Freitag SK. Innovations in treatment of lagophthalmos and exposure keratopathy. Int Ophthalmol Clin. 2017;57(4):85-103. PMID: 28885249
10. Shruti S, Siraj F, Singh A, Ramesh V. Epidermodysplasia verruciformis: three case reports and a brief review. Acta Dermatovenerol Alp Pannonica Adriat. 2017;26(3):59-61. PMID: 28941263
11. Sato Y, Takahashi S, Toshiyasu T, Tsuji H, Hanai N, Homma A. Squamous cell carcinoma of the eyelid. Jpn J Clin Oncol. 2024; 7;54(1):4-12. PMID: 37747408
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Albert Arnaiz-Camacho, Javier Puig-Galy, Sara Martín-Nalda, Laia Bisbe-López, Alfredo Pueyo-Ferrer, Yann Bertolani, Sara García-Hidalgo, Tatiana Pablos-Jiménez, Armand Pairó-Salvador, Miguel-Ángel Zapata (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.